Autologous Blood Collection Set

FDA 510(k) K923016 · Advanced Haemotechnologies

Substantially Equivalent

510(k) numberK923016

Submission

Device name
Autologous Blood Collection Set
Applicant
Advanced Haemotechnologies
The Woodlands, TX, US
Received
June 23, 1992
Decision date
November 23, 1992
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
CAC – Apparatus, Autotransfusion
Device class
Class II (moderate risk)
Regulation
21 CFR 868.5830
Specialty
Anesthesiology
Life-sustaining
Yes

Other 510(k)s with product code CAC

510(k)DeviceApplicantDecision
K241236XTRA Collection sets; XTRA Sequestration set XCAC · Special Sorin Group Italia S.R.L.08/16/2024SE
K240426Aventus Clot Management SystemCAC · Traditional Inquis Medical05/14/2024SE
K240584XTRA Autotransfusion System (with XTRA Bowl sets)CAC · Special Sorin Group Italia S.R.L.04/29/2024SE
K231782FlowSaver Blood Return System (80-101)CAC · Special Inari Medical, Inc.07/14/2023SE
K221483FlowSaver Blood Return SystemCAC · Traditional Inari Medical, Inc.02/17/2023SE
K221722Haemonetics Cell Saver Elite/Elite+ Autotransfusion System (CSE-E-US/CSE-EW-US)CAC · Traditional Haemonetics Corporation11/15/2022SE
K201305Auto transfusion (ATS) Chest Drains: Ocean Water Seal Chest Drain, Oasis Dry Suction…CAC · Traditional Atrium Medical Corporation09/03/2021SE
K210862Hemafuse SystemCAC · Traditional Sisu Global Health07/29/2021SE
K210176FlowSaver Blood FilterCAC · Traditional Inari Medical07/22/2021SE
K210089CATSmart, Automated Blood Processing Autotransfusion SystemCAC · Special Fresenius Kabi AG02/11/2021SE

Questions and answers

When was Autologous Blood Collection Set cleared by the FDA?

Autologous Blood Collection Set (K923016) received a 510(k) decision of Substantially Equivalent on November 23, 1992, 153 days after the submission was received.

What is the product code of K923016?

The FDA product code is CAC – Apparatus, Autotransfusion, a Class II (moderate risk) device regulated under 21 CFR 868.5830.